Indobufen or Aspirin on Top of Clopidogrel After Coronary Drug-Eluting Stent Implantation (OPTION): A Randomized, Open-Label, End Point–Blinded, Noninferiority Trial
Hongyi Wu(Peking University), Guanghe Wei(Affiliated Hospital of Jining Medical University), Juying Qian(Chinese Academy of Medical Sciences & Peking Union Medical College), Yinman Wang(Fudan University), Kang Cheng(Xiamen University), Huanyi Zhang(Taian City Central Hospital), Jiangnan Huang(First Affiliated Hospital of GuangXi Medical University), Manhua Chen(Central Hospital of Wuhan), Chi Zhang(Northeast Agricultural University), Xin Zhao(Soochow University), Junbo Ge(Shanghai Medical College of Fudan University), Jun Lan(Dongguan People’s Hospital), Guangping Li(Qingdao University), Lili Xu(Fudan University), Xiaoyan Wang(Jiangnan University)
Cited by 64
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Sulfur vacancy-rich MoS2 as a catalyst for the hydrogenation of CO2 to methanol
|Nature Catalysis|2021|722
European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism
|European Heart Journal|2018|435
Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
|Circulation|2019|433
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
|Nature Medicine|2016|393